Retraction Note: Down-Regulated Microrna-124 Expression As Predictive Biomarker and Its Prognostic Significance With Clinicopathological Features in Breast Cancer Patients [Diagn Pathol., 10 (2015) (178)]

Retraction Note: Down-Regulated Microrna-124 Expression As Predictive Biomarker and Its Prognostic Significance With Clinicopathological Features in Breast Cancer Patients [Diagn Pathol., 10 (2015) (178)] Publisher

Arabkheradmand A¹ ; Safari A² ; Seifoleslami M² ; Yahaghi E³ ; Gity M⁴

Show Affiliations

1. Tehran University of Medical Sciences, Department of Surgery, Cancer and Reconstructive Surgeon, Cancer Institute, School of Medicine, Tehran, Iran
2. AJA University of Medical Sciences, Department of Gynecology, Khanevadeh Hospital, Tehran, Iran
3. Baqiyatallah University of Medical Sciences, Department of Molecular Biology, Tehran, Iran
4. Tehran University of Medical Sciences, Department of Radiology, Medical Imaging Center, Tehran, Iran

Source: Diagnostic Pathology Published:2016

Abstract

The Editor-in-Chief and Publisher have retracted this article [1] because the scientific integrity of the content cannot be guaranteed. An investigation by the Publisher found it to be one of a group of articles we have identified as showing evidence suggestive of attempts to subvert the peer review and publication system to inappropriately obtain or allocate authorship. This article showed evidence of plagiarism (most notably from the articles cited [2-4]) and authorship manipulation. © The Author(s). 2016.

Style	Citing Format
MLA	Arabkheradmand A, et al.. "Retraction Note: Down-Regulated Microrna-124 Expression As Predictive Biomarker and Its Prognostic Significance With Clinicopathological Features in Breast Cancer Patients [Diagn Pathol., 10 (2015) (178)]." Diagnostic Pathology, vol. 11, no. 1, 2016, pp. -.
APA	Arabkheradmand A, Safari A, Seifoleslami M, Yahaghi E, Gity M (2016). Retraction Note: Down-Regulated Microrna-124 Expression As Predictive Biomarker and Its Prognostic Significance With Clinicopathological Features in Breast Cancer Patients [Diagn Pathol., 10 (2015) (178)]. Diagnostic Pathology, 11(1), -.
Chicago	Arabkheradmand A, Safari A, Seifoleslami M, Yahaghi E, Gity M. "Retraction Note: Down-Regulated Microrna-124 Expression As Predictive Biomarker and Its Prognostic Significance With Clinicopathological Features in Breast Cancer Patients [Diagn Pathol., 10 (2015) (178)]." Diagnostic Pathology 11, no. 1 (2016): -.
Harvard	Arabkheradmand A et al. (2016) 'Retraction Note: Down-Regulated Microrna-124 Expression As Predictive Biomarker and Its Prognostic Significance With Clinicopathological Features in Breast Cancer Patients [Diagn Pathol., 10 (2015) (178)]', Diagnostic Pathology, 11(1), pp. -.
Vancouver	Arabkheradmand A, Safari A, Seifoleslami M, Yahaghi E, Gity M. Retraction Note: Down-Regulated Microrna-124 Expression As Predictive Biomarker and Its Prognostic Significance With Clinicopathological Features in Breast Cancer Patients [Diagn Pathol., 10 (2015) (178)]. Diagnostic Pathology. 2016;11(1):-.
BibTex	@article{ author = {Arabkheradmand A and Safari A and Seifoleslami M and Yahaghi E and Gity M}, title = {Retraction Note: Down-Regulated Microrna-124 Expression As Predictive Biomarker and Its Prognostic Significance With Clinicopathological Features in Breast Cancer Patients [Diagn Pathol., 10 (2015) (178)]}, journal = {Diagnostic Pathology}, volume = {11}, number = {1}, pages = {-}, year = {2016} }
RIS	TY - JOUR AU - Arabkheradmand A AU - Safari A AU - Seifoleslami M AU - Yahaghi E AU - Gity M TI - Retraction Note: Down-Regulated Microrna-124 Expression As Predictive Biomarker and Its Prognostic Significance With Clinicopathological Features in Breast Cancer Patients [Diagn Pathol., 10 (2015) (178)] JO - Diagnostic Pathology VL - 11 IS - 1 SP - EP - PY - 2016 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract